Literature DB >> 18952691

Prevalence of Dientamoeba fragilis among patients consulting complementary medicine practitioners in the British Isles.

H Schuster1, R S Jackson.   

Abstract

A high prevalence of Dientamoeba fragilis is reported in faecal samples collected from patients attending complementary medicine practitioners in the British Isles. Specimens were collected directly after passing into sodium acetate-acetic acid-formalin (SAF). During two observation periods in 2002-04 and 2005-07, a D fragilis prevalence of 14.6% (n = 543) and 16.9% (n = 421), respectively, was recorded. These results confirm a surprisingly high prevalence of D fragilis among a selected population. Clinical information was only available for half of the patients with D fragilis; 50% of requests with clinical information reported gastrointestinal symptoms. For further work on its pathogenic role and prevalence among patients with gastrointestinal symptoms, immediate collection in SAF should be considered the optimal sampling modality for UK based laboratories.

Entities:  

Mesh:

Year:  2008        PMID: 18952691     DOI: 10.1136/jcp.2008.059659

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria.

Authors:  Javed Yakoob; Wasim Jafri; Mohammad Asim Beg; Zaigham Abbas; Shagufta Naz; Muhammad Islam; Rustam Khan
Journal:  Parasitol Res       Date:  2010-06-08       Impact factor: 2.289

Review 2.  Does Dientamoeba fragilis cause diarrhea? A systematic review.

Authors:  Zing-Wae Wong; Kate Faulder; Joan L Robinson
Journal:  Parasitol Res       Date:  2018-02-05       Impact factor: 2.289

Review 3.  Dientamoeba fragilis, One of the Neglected Intestinal Protozoa.

Authors:  Lynne S Garcia
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

4.  A review of the clinical presentation of dientamoebiasis.

Authors:  Damien Stark; Joel Barratt; Tamalee Roberts; Deborah Marriott; John Harkness; John Ellis
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

5.  ME/CFS and Blastocystis spp or Dientamoeba fragilis, an in-house comparison.

Authors:  David Dunwell
Journal:  Br J Gen Pract       Date:  2013-02       Impact factor: 5.386

6.  Comparison and Recommendations for Use of Dientamoeba fragilis Real-Time PCR Assays.

Authors:  Rory Gough; John Ellis; Damien Stark
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

7.  Prevalence and associated factors of intestinal parasitisation: a cross-sectional study among outpatients with gastrointestinal symptoms in Catalonia, Spain.

Authors:  Olga González-Moreno; Laia Domingo; Jaume Teixidor; Mercedes Gracenea
Journal:  Parasitol Res       Date:  2010-09-23       Impact factor: 2.289

Review 8.  Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.

Authors:  Damien Stark; Joel Barratt; Douglas Chan; John T Ellis
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

9.  Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults?

Authors:  Jaap J van Hellemond; Nicky Molhoek; Rob Koelewijn; Pieter J Wismans; Perry J J van Genderen
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-14       Impact factor: 4.077

10.  Genetic diversity of Dientamoeba fragilis isolates of irritable bowel syndrome patients by high-resolution melting-curve (HRM) analysis.

Authors:  Eman M Hussein; Hamdan I Al-Mohammed; Abdalla M Hussein
Journal:  Parasitol Res       Date:  2009-06-19       Impact factor: 2.289

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.